Caudal Versus Intravenous Dexmedetomidine for Caudal Analgesia in Children

PHASE2CompletedINTERVENTIONAL
Enrollment

75

Participants

Timeline

Start Date

January 31, 2014

Primary Completion Date

October 31, 2014

Study Completion Date

October 31, 2014

Conditions
Pain
Interventions
DRUG

Caudal Dexmedetomidine

"Drug:Caudal bupivacaine 0.25% 1ml/kg~Drug: Caudal dexmedetomidine 1µg/kg~Intravenous: 10 ml normal saline~sevoflurane Induction and maintenance of anesthesia"

DRUG

Intravenous dexmedetomidine

"Drug:Caudal bupivacaine 0.25% 1ml/kg.~Drug:Intravenous dexmedetomidine1 μg /kg in a total volume of 10 ml~sevoflurane Induction and maintenance of anesthesia"

DRUG

Placebo

"Drug:Caudal bupivacaine 0.25% 1ml/kg~Intravenous: Normal saline 10 ml~sevoflurane Induction and maintenance of anesthesia"

All Listed Sponsors
lead

University of Jordan

OTHER

NCT02416063 - Caudal Versus Intravenous Dexmedetomidine for Caudal Analgesia in Children | Biotech Hunter | Biotech Hunter